Abyrx,™ Inc. Receives FDA 510(k) Clearance for New Hemasorb Plus™ Resorbable Hemostatic Bone Putty

Hemasorb Plus is provided ready-to-use and achieves hemostasis by mechanical tamponade. Its proprietary formulation is comprised of granular hydroxyapatite/beta-tricalcium phosphate and water soluble components that are fully synthetic and absorbable.

Abyrx,™ Inc. Receives FDA 510(k) Clearance for New Resorbable Hemostatic Bone Putty (Hemasorb Plus™) (via PR Newswire)

IRVINGTON, N.Y., Sept. 4, 2013 /PRNewswire/ — Abyrx, Inc., a privately-held therapeutic device company, today announced that the United States Food and Drug Administration has cleared its new resorbable hemostatic bone putty (Hemasorb Plus™) for…

published: September 5, 2013 in: Approval/Clearance, General Surgery, Techniques

Most read

Latest

^